IRF4 and Burkitt lymphoma: Expression of IRF4 is associated with resistance to treatment of viral cancers with IFN/AZT, and AZT specifically induces apoptosis as well as initiates the viral lytic program in Type I EBV+ Burkitt’s lymphomas [21].